These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 27932479)

  • 1. Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis.
    Sayer JA
    J Am Soc Nephrol; 2017 Mar; 28(3):748-759. PubMed ID: 27932479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of kidney stone disease.
    Howles SA; Thakker RV
    Nat Rev Urol; 2020 Jul; 17(7):407-421. PubMed ID: 32533118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of kidney stone disease and nephrocalcinosis.
    Singh P; Harris PC; Sas DJ; Lieske JC
    Nat Rev Nephrol; 2022 Apr; 18(4):224-240. PubMed ID: 34907378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal stone disease.
    Sayer JA
    Nephron Physiol; 2011; 118(1):p35-44. PubMed ID: 21071986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.
    Guerra A; Ticinesi A; Allegri F; Nouvenne A; Pinelli S; Folesani G; Lauretani F; Maggio M; Borghi L; Meschi T
    Urolithiasis; 2016 Nov; 44(6):521-528. PubMed ID: 27038481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium kidney stones. Diagnostic and preventive prospects].
    Arcidiacono T; Terranegra A; Biasion R; Soldati L; Vezzoli G
    G Ital Nefrol; 2007; 24(6):535-46. PubMed ID: 18278757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characteristics of genetic disease in adult kidney stone formers.
    Anderegg MA; Olinger EG; Bargagli M; Geraghty R; Taylor L; Nater A; Bruggmann R; Sayer JA; Vogt B; Schaller A; Fuster DG
    Nephrol Dial Transplant; 2024 Aug; 39(9):1426-1441. PubMed ID: 38544324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and calcium nephrolithiasis.
    Vezzoli G; Terranegra A; Arcidiacono T; Soldati L
    Kidney Int; 2011 Sep; 80(6):587-93. PubMed ID: 20962745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.
    Wang X; Krambeck AE; Williams JC; Tang X; Rule AD; Zhao F; Bergstralh E; Haskic Z; Edeh S; Holmes DR; Herrera Hernandez LP; Lieske JC
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1757-63. PubMed ID: 25092598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The composition and quantitative analysis of urinary calculi in patients with renal calculi.
    Jawalekar S; Surve VT; Bhutey AK
    Nepal Med Coll J; 2010 Sep; 12(3):145-8. PubMed ID: 21446361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model of nephrolithiasis involving tubular dysfunction/injury.
    Kumar S; Sigmon D; Miller T; Carpenter B; Khan S; Malhotra R; Scheid C; Menon M
    J Urol; 1991 Nov; 146(5):1384-9. PubMed ID: 1942307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of kidney stone formation: an analysis.
    Khan SR
    World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones.
    Chow K; Dixon J; Gilpin S; Kavanagh JP; Rao PN
    Kidney Int; 2004 May; 65(5):1724-30. PubMed ID: 15086911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future perspective on the prevention of nephrolithiasis].
    Kohjimoto Y; Shinka T; Morimoto S; Nishihata M
    Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.